IGFBP3 and coronary artery disorder: This study aimed to address this gap by prospectively comparing IGF‐1 and IGFBP‐3 levels in cord blood between neonates with critical CHD (CCHD) and healthy controls, as well as between cases with normal vs lower predicted cerebral oxygen delivery (COD) in utero.